SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000812796-09-000012
Filing Date
2009-03-16
Accepted
2009-03-16 16:36:09
Documents
4
Period of Report
2009-03-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8K FOR NEW DIRECTOR LAPOINTE AND OFFICER HAMILTON dor8klapointehamilton.htm 8-K 32350
2 HAMILTON EMPLOYMENT AGREEMENT hamiltonemploymentagreement.htm EX-10.1 54762
3 PRESS RELEASE FOR LAPOINTE pressreleaselapointe.htm EX-99.1 14309
4 PRESS RELEASE FOR HAMILTON pressreleasehamilton.htm EX-99.2 16535
  Complete submission text file 0000812796-09-000012.txt   119780
Mailing Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628
Business Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628 609-538-8200
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 09684820
SIC: 2834 Pharmaceutical Preparations